These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26776196)

  • 21. Advancing cancer drug development through precision medicine and innovative designs.
    Zhang W; Wang J; Menon S
    J Biopharm Stat; 2018; 28(2):229-244. PubMed ID: 29173004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using observational data for personalized medicine when clinical trial evidence is limited.
    Gershman B; Guo DP; Dahabreh IJ
    Fertil Steril; 2018 Jun; 109(6):946-951. PubMed ID: 29935652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise in cancer survivors: an overview of research.
    Courneya KS
    Med Sci Sports Exerc; 2003 Nov; 35(11):1846-52. PubMed ID: 14600549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward precision medicine of breast cancer.
    Carels N; Spinassé LB; Tilli TM; Tuszynski JA
    Theor Biol Med Model; 2016 Feb; 13():7. PubMed ID: 26925829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.
    Richman SD; Southward K; Chambers P; Cross D; Barrett J; Hemmings G; Taylor M; Wood H; Hutchins G; Foster JM; Oumie A; Spink KG; Brown SR; Jones M; Kerr D; Handley K; Gray R; Seymour M; Quirke P
    J Pathol; 2016 Mar; 238(4):562-70. PubMed ID: 26690310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enabling semantic interoperability in multi-centric clinical trials on breast cancer.
    Alonso-Calvo R; Perez-Rey D; Paraiso-Medina S; Claerhout B; Hennebert P; Bucur A
    Comput Methods Programs Biomed; 2015 Mar; 118(3):322-9. PubMed ID: 25682737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.
    Newman LA; Hurd T; Leitch M; Kuerer HM; Diehl K; Lucci A; Giuliano A; Hunt KK; Putnam W; Wells SA
    J Am Coll Surg; 2004 Oct; 199(4):644-51. PubMed ID: 15454152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis for the early detection and rational treatment of cancer--realistic hope?
    Posadas EM; Simpkins F; Liotta LA; MacDonald C; Kohn EC
    Ann Oncol; 2005 Jan; 16(1):16-22. PubMed ID: 15598930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands.
    Mol L; Koopman M; van Gils CW; Ottevanger PB; Punt CJ
    Acta Oncol; 2013 Jun; 52(5):950-5. PubMed ID: 23517248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IDENTIFICATION OF QUESTIONABLE EXCLUSION CRITERIA IN MENTAL DISORDER CLINICAL TRIALS USING A MEDICAL ENCYCLOPEDIA.
    Ma H; Weng C
    Pac Symp Biocomput; 2016; 21():219-30. PubMed ID: 26776188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics: Big hopes for big data.
    Adams JU
    Nature; 2015 Nov; 527(7578):S108-9. PubMed ID: 26580158
    [No Abstract]   [Full Text] [Related]  

  • 34. OncoRep: an n-of-1 reporting tool to support genome-guided treatment for breast cancer patients using RNA-sequencing.
    Meißner T; Fisch KM; Gioia L; Su AI
    BMC Med Genomics; 2015 May; 8():24. PubMed ID: 25989980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CATTLE (CAncer treatment treasury with linked evidence): An integrated knowledge base for personalized oncology research and practice.
    Soysal E; Lee HJ; Zhang Y; Huang LC; Chen X; Wei Q; Zheng W; Chang JT; Cohen T; Sun J; Xu H
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):188-196. PubMed ID: 28296354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical research in small genomically stratified patient populations.
    Martin-Liberal J; Rodon J
    Eur J Cancer; 2017 Jul; 80():73-82. PubMed ID: 28591680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bringing Precision Medicine to Community Oncologists.
    Cancer Discov; 2017 Jan; 7(1):6-7. PubMed ID: 27864232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
    Liu J; Lichtenberg T; Hoadley KA; Poisson LM; Lazar AJ; Cherniack AD; Kovatich AJ; Benz CC; Levine DA; Lee AV; Omberg L; Wolf DM; Shriver CD; Thorsson V; ; Hu H
    Cell; 2018 Apr; 173(2):400-416.e11. PubMed ID: 29625055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials.
    O'Regan P; Hoskins R; Grave C; Stevenson JA; Frost H; Graham DM; Krebs MG; Freitas A; Landers D
    JCO Clin Cancer Inform; 2023 Jan; 7():e2200137. PubMed ID: 36657092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.